97028 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Receptors; Cell surface antigens; Cell surface determinants
Monoclonal antibodies against dendritic cell receptor
#3002Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#3003Prostate-specific membrane antigen and uses thereof
#3004TREM-2 gene and protein as inhibitors of expression of GA733-2, and transgenic animals comprising the same and uses thereof
#3005PEPTIDE GAP JUNCTION MODULATORS
#3006CSF-1R MUTANTS
#3007Cell lines expressing ENaC and methods using them
#3008Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells
#3009Trimerizing polypeptides
#3010NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM
#3011Induced internalization of surface receptors
#3012Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 Antagonists and TrkB Agonists
#3013MODIFIED T CELL RECEPTORS AND RELATED MATERIALS AND METHODS
#3014Polynucleotides and polypeptide of human KV1.3, compositions comprising same and methods of using same
#3015c-MET kinase binding proteins
#3016Isolated AEBP1 genomic polynucleotide fragments from chromosome 7 and their uses
#3017Tumor associated antigen peptides and use of same as anti-tumor vaccines
#3018Protein showing enhanced expression in cancer cells
#3019PERIPHERAL AND NEURAL INFLAMMATORY CROSSTALK
#3020Cardiac Conduction System (CCS) Progenitor Cells and Uses Thereof
#3021Novel Polypeptide, cDNA Encoding the Same, and Use Thereof
#3022Compositions and methods for fusion protein separation
#3023Expression of Anti-Nociceptive Compounds from Endogenously Regulated Promoters
#3024Proteins
#3025Method for inhibiting release of hepatitis B virus from liver cells
#3026Transporter protein in mammal and utilization of the same
#3027METHOD FOR THE STABILISATION OF PURIFIED P-GLYCOPROTEIN
#3028Method of identifying transmembrane protein-interacting compounds
#3029Nogo receptor-mediated blockade of axonal growth
#3030METHOD OF ENHANCING PROLIFERATION AND/OR HEMATOPOIETIC DIFFERENTIATION OF STEM CELLS
#3031Notch-based fusion proteins and uses thereof
#3032DIAGNOSIS AND TREATMENT OF CANCER: I
#3033Human Potassium Channel Genes
#3034PKHDL1, A HOMOLOG OF THE AUTOSOMAL RECESSIVE KIDNEY DISEASE GENE
#3035Truncated proteins as cancer markers
#3036Antibodies to tumor associated proteins
#3037Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins
#3038NOVEL SERPENTINE TRANSMEMBRANE ANTIGENS EXPRESSED IN HUMAN CANCERS AND USES THEREOF
#3039Immunity to folate receptors
#3040Voltage gated calcium channel β-subunit anchoring regulator protein and uses thereof
#3041Method of treating or retarding the development of blindness
#3042RECEPTOR
#3043METHODS, COMPOSITIONS AND TRANSGENIC MODELS RELATED TO THE INTERACTION OF T-CADHERIN AND ADIPONECTIN
#3044Slo2, novel potassium channel proteins from human brain
#3045Methods and compositions for treating pain
#3046MODULATING PHOTOREACTIVITY IN A CELL
#3047Soluble inhibitors of vascular endothelial growth factor and use thereof
#3048Actriib-Fc polynucleotides, polypeptides, and compositions
#3049Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domains
#3050Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease
#3051D1-1 NUCLEIC ACIDS, POLYPEPTIDES AND RELATED METHODS
#3052HUMAN RECEPTOR PROTEINS; RELATED REAGENTS AND METHODS
#3053Use of DR3 antibodies in the treatment of inflammatory disease
#3054Animal model for chronic obstructive pulmonary disease and cystic fibrosis
#3055LY6H POLYPEPTIDE
#3056Glycoprotein VI and uses thereof
#3057Stable cell lines expressing hERG
#3058ANTIBODIES SPECIFICALLY REACTIVE WITH A TUMOR NECROSIS FACTOR RELATED LIGAND
#3059Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#3060MAINTENANCE OF HAIR GROWTH AND TREATMENT OF HAIR-LOSS
#3061Botulinum neurotoxin A receptor and the use thereof
#3062STRATEGY FOR CLONING AND EXPRESSING THE EXTRACELLULAR DOMAINS OF RECEPTORS AS SOLUBLE PROTEINS
#3063Human T2R51 taste receptor nucleic acid sequences and polypeptides
#3064Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Cardiac Disease
#3065Truncated variant of the mammalian target for rapamycin (MTOR) protein
#3066Hemopoietin receptor protein, NR10
#3067Hemopoietin receptor protein, NR10
#3068MODULATION OF GLUCAGON RECEPTOR EXPRESSION
#3069Delivery of a light-activated cation channel into the brain of a subject
#3070Protein production in microorganisms of the phylum labyrinthulomycota
#3071Microorganisms for imaging and/or treatment of tumors
#3072ANTIBODY RECOGNIZING ANTIGEN
#3073Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
#3074Humanin receptor or humanin-like polypeptide receptor
#3075Peptidic antagonists of class III semaphorins/neuropilins complexes
#3076Nucleic Acids Encoding a Functional Mammalin Purinoreceptor, P2X3, Methods of Production and Use Thereof
#3077Patched polypeptides and uses related thereto
#3078Directed engagement of activating Fc receptors
#3079Protease activatable interferon alpha proprotein
#3080NOVEL PROTEINS WITH TARGETED BINDING
#3081Diagnostic Assay
#3082METHODS FOR RELIEVING NEUROPATHIC PAIN BY MODULATING ALPHA 1G T-TYPE CALCIUM CHANNELS AND MICE LACKING ALPHA 1G T-TYPE CALCIUM CHANNELS
#3083Diagnostic Methods for HIV Infection
#3084Methods and compositions using FGF23 fusion polypeptides
#3085ANGIOGENESIS-INHIBITING CHIMERIC PROTEINS AND THE USE
#3086COMPOSITIONS AND METHODS OF MODULATING THE TASTE AND SMELL RECEPTORS AND SCREENING METHODS THEREFORE
#3087Biosensors to measure InsP3 concentration in living cells
#3088Cyclic receptor-associated protein (RAP) peptides
#3089Antibodies to tumor associated proteins
#3090HELICAL SYNTHETIC PEPTIDES THAT STIMULATE CELLULAR CHOLESTEROL EFFLUX
#3091Methods for identifying inhibitors of botulinum neurotoxins
#3092Protein scaffolds and uses thereof
#3093Diagnostic method for epilepsy
#3094Methods and compositions for treating melanoma
#3095Role of proteoglycans in drug dependence
#3096Parstatin peptides and uses thereof
#3097System and method for streaming a lottery game
#3098Transporter genes OATP-B, C, D, and E
#3099Metastatic colorectal cancer vaccine
#3100LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
#3101Modulation of blood brain barrier protein expression
#3102Removal promoters and inhibitor for apoptosis cells in vivo
#3103SECRETED PATE-LIKE PROTEINS
#3104Modulation of Mu Delta Opioid Receptor Expression
#3105Serpentine transmembrane antigens expressed in human cancers and uses thereof
#3106Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system
#3107Generation of antigen specific T cells
#3108Use of semaphorin 6A for promoting myelination and oligodendrocyte differentiation
#3109METHODS AND COMPOSITIONS TO TREAT ARRHYTHMIAS
#3110Albumin Fusion Proteins
#3111Peptide Derived From Prostate-Related Protein As Cancer Vaccine Candidate For Prostate Cancer Patient Who Is Positive For Hla-A3 Super-Type Allele Molecule
#3112Binding molecules for the treatment of myeloid cell malignancies
#3113METHOD OF TREATING ABNORMAL ANGIOGENESIS VIA THE BAI FAMILY OF PROTEINS AND THEIR PROTEIN FRAGMENTS
#3114Stitched polypeptides
#3115Bis-sulfhydryl macrocyclization systems
#3116Guanosine triphosphate (GTP)-binding protein-coupled receptor protein, BG37
#3117Screening methods using sitosterolemia susceptibility gene (SSG) polypeptides
#3118Ligand gated ion channels from
#3119Therapies for cancer using RLIP76
#3120Conjugates of surface proteins as malaria vaccines
#3121METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS AND IMPAIRED LUNG FUNCTION AND TO ENHANCE LYMPHOCYTE PRODUCTION
#3122Glycosylated specificity exchangers
#3123Methods for increasing adiponectin in a patient in need thereof
#3124Tweak receptor
#3125Reversed mammalian protein-protein interaction trap
#3126METHODS AND USES RELATED TO RHBDL4
#3127Eukaryotic layered vector initiation systems
#3128NOVEL NOTCH-ORIGIN POLYPEPTIDES AND BIOMARKERS AND REAGENTS USING THE SAME
#3129Serpentine transmembrane antigens expressed in human cancers and uses thereof
#3130Method of treatment of diabestes or reduction in pancreatic beta-cells
#3131Treatment of stroke using domain V of perlecan
#3132Toll-like receptor 3 antagonists
#3133S100A9 interaction screening method
#3134SYNTHETIC MIMICS OF MAMMALIAN CELL SURFACE RECEPTORS: METHOD AND COMPOSITIONS
#3135ACETYLYCHOLINE GATED ION CHANNEL CHAPERONS AND METHODS OF USING THE SAME
#3136Permissive cells and uses thereof
#3137Polypeptides and polynucleotides encoding same
#3138RECEPTOR
#3139Phenylthiocarbamide (PTC) taste receptor
#3140HIGH AFFINITY EPHB RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF
#3141TRANSGENIC ANIMAL MODEL FOR MODELLING PATHOLOGICAL ANXIETY, A METHOD FOR IDENTIFYING COMPOUNDS FOR TREATMENT OF DISEASES OR DISORDERS CAUSED BY PATHOLOGICAL ANXIETY AND A METHOD FOR USING WFS1 PROTEIN AS A TARGET FOR IDENTIFYING EFFECTIVE COMPOUNDS AGAINST PATHOLOGICAL ANXIETY
#3142Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof
#3143RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)
#3144METHOD FOR SCREENING AGENTS FOR THE TREATMENT OF DIABETES
#3145LYSOPHOSPHATIDIC ACID RECEPTOR TARGETING FOR LUNG DISEASE
#3146Diagnostic and therapeutic target for autoimmune diseases and uses thereof
#3147CD161 ligand, pilar, for modulating activation and proliferation of T cells
#3148CADHERIN-11-MEDIATED MODULATION OF HAIR GROWTH
#3149G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same
#3150Removal promoters and inhibitor for apoptosis cells in vivo
#3151ANTIBODIES THAT BIND TO OBM
#3152TACI-Fc fusion proteins, methods of making and uses thereof
#3153ANTIBODIES RECOGNIZING OXYGEN-REGULATED PROTEIN 150 EXPRESSED ON CANCER CELLS AND METHODS OF USING SAME
#3154Artery- and vein-specific proteins and uses therefor
#3155Methods and compositions for the treatment and prevention of HIV infection using TRIM5α
#3156METHODS FOR INHIBITING OCULAR ANGIOGENESIS
#3157METHOD FOR DECREASING DEPRESSION BY INHIBITING THE ACTIVITY OF ALPHA 1B SUBUNIT OF N-TYPE CALCIUM CHANNEL
#3158METHODS AND COMPOSITIONS FOR TREATING CERVICAL CANCER
#3159SUBSTANCE WITH ANTITHROMBOTIC ACTIVITY AND METHOD FOR DETECTING GLYCOKALLIDIN
#3160INDUCTION OF APOPTOSIS AND CELL GROWTH INHIBITION BY PROTEIN 4.33
#3161Methods of using an alpha-1-adrenergic receptor having altered ligand affinity
#3162Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
#3163Stimulation of Pancreatic Beta Cell Proliferation
#3164Use of the conserved Drosophila NPFR1 system for uncovering interacting genes and pathways important in nociception and stress response
#3165SOLUBLE LOW-DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN BINDS DIRECTLY TO ALZHEIMER'S AMYLOID-BETA PEPTIDE
#3166PLEXIN D1 AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY
#3167Plant cyclopropane fatty acid synthase genes, proteins, and uses thereof
#3168Scavenger receptor
#3169Monoclonal antibody against human scavenger receptor SRCL-P1
#3170Mutation Implicated in Abnormality of Cardiac Sodium Channel Function
#3171MULTIMERIC Fc RECEPTOR POLYPEPTIDES INCLUDING A MODIFIED Fc DOMAIN
#3172Antibodies to proteolysis inducing factor (PIF) receptor and methods of use thereof
#3173Development of influenza A antivirals
#3174TREATMENT OF PAIN THROUGH EXPRESSION OF OPIOID RECEPTORS
#3175Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs
#3176Botulinum neurotoxin E receptors and uses thereof
#3177System for monitoring the location of transgenes
#3178Methods for identifying stem cells expressing breast cancer resistance protein (BCRP)
#3179PROTEINS
#3180PROTEINS
#3181Protein
#3182Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy
#3183Smoothened polypeptides and methods of use
#3184COMPOSITIONS AND METHODS FOR MODULATING NOD-LIKE RECEPTOR ACTIVITY AND USES THEREOF
#3185Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene
#3186FGFR extracellular domain acidic region muteins
#3187Glycan modified soluble receptors and binding protein and their use
#3188NOTCH mutations leading to increased receptor signaling
#3189Polynucleotides encoding toll-like receptor 3
#3190Isolated snare YKT6 genomic polynucleotide fragments from chomosome 7 and their uses
#3191Methods of treating inflammatory disorders of the lungs
#3192GBS TOXIN RECEPTOR
#3193Genetic modification of targeted regions of the cardiac conduction system
#3194Peptide mimotopes that inhibits interaction between a platelet receptor and a platelet receptor ligand
#3195N-terminal VDAC variants and uses thereof
#3196T1R taste receptors and genes encoding same
#3197Methods for promoting myelination, neuronal survival and oligodendrocyte differentiation via administration of Sp35 or TrkA antagonists
#3198Selective Inhibition of TLR4 Signaling
#3199MAMMALIAN CHEMOKINES; RECEPTORS; REAGENTS; USES
#3200Cloned glucagon-like peptide-2 receptors
#3201Method and Compositions for Stimulation of an Immune Response to TRP2 using a Xenogeneic TRP2 Antigen
#3202Method and Compositions for Stimulation of an Immune Response to PSMA using a Xenogeneic PSMA Antigen
#3203Methods of using Fc-cytokine fusion proteins
#3204Bispecific fusion protein having therapeutic and diagnostic potential
#3205Methods for identifying compounds which bind to TANGO294
#3206Nucleic acids encoding T2R taste receptors
#3207Markers, Antibodies and Recombinant scFvs for Mesenchymal Stem Cell Sub-populations and Osteoclasts
#3208THERAPEUTIC USES OF TIM-3 MODULATORS
#3209Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
#3210GLUT-1 as a receptor for HTLV envelopes and its uses
#3211VACCINE AGAINST BURKHOLDERIA INFECTIONS
#3212Prostate stem cell antigen (PSCA) variants and subsequences thereof
#3213System and method for monitoring and analyzing internet traffic
#3214Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate
#3215Fn14/TRAIL fusion proteins
#3216ENDOGENOUS AND NON-ENDOGENOUS VERSIONS OF HUMAN G PROTEIN-COUPLED RECEPTORS
#3217COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES CHARACTERIZED BY A-33 RELATED ANTIGENS
#3218Insect chemosensory receptors and methods of use thereof
#3219Nucleic acids encoding IL-17 homologous receptor-like polypeptides and therapeutic uses thereof
#3220REAGENT FOR DETECTION OF AUTOANTIBODY AND KIT FOR DIAGNOSIS OF AUTOIMMUNE DISEASE
#3221Variants of human taste receptor genes
#3222USE OF INHIBITORS OF LEUKOTRIENE B4 RECEPTOR BLT2 FOR TREATING ASTHMA
#3223Use of ionic liquids for membrane protein extraction
#3224Synthetic mimics of mammalian cell surface receptors: method and compositions
#3225Chimeric NK receptor and methods for treating cancer
#3226Nucleic acid molecules encoding GPR84
#3227LRRTM1 Compositions and Methods of Their Use for the Diagnosis and Treatment of Cancer
#3228Receptor associated protein (RAP) conjugates
#3229Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
#3230NoGo Receptor 1 and Fibroblast Growth Factor Interactions
#3231Antibodies that bind human OX2 receptors
#3232LIGHT-SENSITIVE CONSTRUCTS FOR INDUCING CELL DEATH AND CELL SIGNALING
#3233Neuronal exocytosis inhibiting peptides
#3234METHOD OF DETECTING A CANCER CELL BY ABERRANT EXPRESSION OF A HUMAN K+ ION CHANNEL
#3235Molecular probe for sphingolipids
#3236Compositions comprising MG29 nucleic acids, polypeptides, and associated methods of use
#3237PRRG4-associated compositions and methods of use thereof in methods of tumor diagnosis
#3238Hemopoietic receptor protein, NR10
#3239Nucleic acid sequences and their use in methods to identify umami modulatiors
#3240Compositions and methods for treating kidney disease
#3241METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE MEMORY BY BLOCKING INTRAHEPATIC ACTIVATED T CELL DELETION
#3242Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
#3243Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
#3244NPC1L1 (NPC3) and methods of identifying ligands thereof
#3245System and method for controlling G-protein coupled receptor pathways
#3246RBP4 in insulin sensitivity/resistance, diabetes, and obesity
#3247Peptides and regulation of calcium channels
#3248Biometric broadband gaming system and method
#3249CHIMERIC VACCINE ANTIGENS AGAINST THE AVIAN INFLUENZA VIRUS
#3250Isolated DNA directed 50kD regulatory subunit (POLD2) genomic polynucleotide fragments from chomosome 7 and their uses
#3251Isolated SNARE YKT6 genomic polynucleotide fragments from chromosome 7 and their uses
#3252METHODS AND COMPOSITIONS FOR MODULATING T CELL AND/OR B CELL ACTIVATION
#3253ULBP antibodies
#3254T-cell receptor and nucleic acid encoding the receptor
#3255Antibodies to PRO352
#3256IL-17 homologous polypeptides and therapeutic uses thereof
#3257Mutations in ion channel proteins associated with sudden cardiac death
#3258CELLULAR ASSAYS FOR SIGNALING RECEPTORS
#3259Two pore channels as regulators of proliferation in cancer
#3260Methods of identifying candidate compounds of the human G protein-coupled receptor, GPR50, as modulators of body mass or adiposity
#3261Genetically Modified Animal and Use Thereof
#3262GPR22 AND METHODS RELATING THERETO
#3263Methods of effecting Wnt signaling through Dkk structural analysis
#3264TLR4 decoy receptor protein
#3265Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
#3266Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
#326712 human secreted proteins
#3268Compositions of and Methods of Using Stabilized PSMA Dimers
#3269CALCIUM-ACTIVATED CHLORIDE CHANNEL AND METHODS OF USE THEREOF
#3270Muteins of tear lipocalin and methods for obtaining the same
#3271Secreted protein acidic and rich in cysteine (SPARC) as chemotherapeutic sensitizers
#3272Cancer-associated antigen
#3273Nogo-B receptor antagonists
#3274GLYCOSYLATED SPECIFICITY EXCHANGER
#3275ANTIGENIC SURFACE STRUCTURE OF SPERM CELLS ASSOCIATED WITH THE Y CHROMOSOME
#3276BIOLOGICALLY EXCITABLE CELLS
#3277COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#3278Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use
#3279Milk fat globule epidermal growth factor—factor VIII and sepsis
#3280Novel Gene Disruptions, Compositions and Methods Relating Thereto
#3281Human cDNA Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their Use
#3282Collagen Receptor I-Domain Binding Modulators
#3283Chimeric proteins and their use in methods to screen for sweet taste modulators
#3284EPITOPE SEQUENCES
#3285Albumin Fusion Proteins
#3286Calcium-sensing receptor 2 (CaR2) and methods for using
#3287Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
#3288Yeast cell surface display of proteins and uses thereof
#3289Methods for identifying modulators of SF taste receptor signaling
#3290Interactive dental restorative network
#3291G-Protein Coupled Receptor 83 As a Molecular Switch for the Induction of Regulatory (immunosuppressive) T-cells
#3292Use of A33 antigens and JAM-IT
#3293Human T1R2 taste receptor nucleic acids and cells containing these nucleic acids
#3294UL16 binding protein 4
#3295Methods for the identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease
#3296Dendritic Cells Transiently Transfected with a Membrane Homing Polypeptide and their use
#3297G protein coupled receptor antagonists and methods of activating and inhibiting G protein coupled receptors using the same
#3298Transmembrane delivery peptide and bio-material comprising the same
#3299Compositions comprising receptor-associated protein (RAP) variants specific for LRP2 and uses thereof
#3300CRYSTAL STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR AMINO TEMINAL FRAGMENT BOUND TO ITS RECEPTOR